Edition:
United States

Syngenta AG (SYT)

SYT on New York Consolidated

92.15USD
16 Aug 2017
Change (% chg)

$0.15 (+0.16%)
Prev Close
$92.00
Open
$92.05
Day's High
$92.24
Day's Low
$92.00
Volume
29,966
Avg. Vol
653,569
52-wk High
$93.61
52-wk Low
$74.52

Latest Key Developments (Source: Significant Developments)

Syngenta CEO highlights contribution to U.S. exports
Wednesday, 8 Feb 2017 05:30am EST 

Syngenta :CEO, asked about business under U.S. Trump administration, says we are part of significant exports.  Full Article

Syngenta CEO says has seen stabilization in crop prices -CNBC
Wednesday, 8 Feb 2017 01:30am EST 

: Syngenta CEO says has seen stabilization in crop prices, unsure when prices will rise again, expects markets to start to grow again in 2017 -CNBC Further company coverage: [SYNN.S] (Reporting by Zurich Newsroom) ((zurich.newsroom@thomsonreuters.com; +41 58 306 7336;)).  Full Article

Syngenta confirms remedy proposal submitted, remains confident in deal
Tuesday, 10 Jan 2017 02:20am EST 

Syngenta Ag :Spokesman confirms remedy proposal has been submitted to eu, confident transaction will successfully be closed.  Full Article

Moody's says ChemChina's rating unaffected by EU's extended anti-trust investigation into Syngenta acquisition
Thursday, 5 Jan 2017 03:55am EST 

: Moody's: ChemChina's rating unaffected by EU's extended anti-trust investigation into Syngenta acquisition . Moody's: ChemChina's negative rating outlook captures risk of a potentially weaker credit profile for the company, after its acquisition of Syngenta .Moody's: outlook reflects risk if Syngenta acquisition does not proceed, ChemChina's credit profile would remain similar to that before takeover offer.  Full Article

Syngenta focused on getting ChemChina deal done - CEO
Friday, 22 Jul 2016 03:59am EDT 

: Syngenta ceo says we are focused on getting ChemChina deal done . Syngenta ceo says u.k. is a very important market for us .Syngenta cfo says most shareholders will wait until we get the final approval for takeover before tendering their shares.  Full Article

BRIEF-Syngenta CFO - doesn't look like crop prices will improve in short term
Friday, 22 Jul 2016 03:30am EDT 

Corrects to say in 2nd bullet point doesn't look like crop prices will improve in short term, not 2nd half.Syngenta : CFO says going into 2nd half currencies are looking to have fairly neutral effect . CFO tells reuters doesn’t look like crop prices are going to improve in short term Further company coverage: [SYNN.S] (Reporting by Zurich newsroom) ((zurich.newsroom@thomsonreuters.com; +41 58 306 7336;)) Keywords: (CORRECTED).  Full Article

ChemChina extends public tender offers for Syngenta
Monday, 11 Jul 2016 01:00am EDT 

: ChemChina extends public tender offers for Syngenta . ChemChina says extends tender offers for all publicly held registered shares of Syngenta and all outstanding American depositary shares representing common shares until Sept. 13 unless further extended . ChemChina says all of other terms and conditions of tender offers remain unchanged and ChemChina continues to expect to conclude transaction by end of year Further company coverage: [SYNN.S] (Reporting By Zurich newsroom) ((zurich.newsroom@thomsonreuters.com; +41 58 306 7336;)).  Full Article

Stockton Group, Syngenta enter into a global development and distribution agreement
Monday, 27 Jun 2016 04:55pm EDT 

Stockton Group: The Stockton Group and Syngenta have entered into a global development and distribution agreement for a new biofungicide technology .Products of Stockton will be sold under Syngenta brand for botrytis and powdery mildew in ornamentals globally.  Full Article

Syngenta launches new biological seed treatment
Thursday, 12 May 2016 01:13am EDT 

Syngenta AG : Launches new biological seed treatment .Announced launch of EPIVIO(tm) brand family, a range of new biostimulants which address abiotic stresses through seed treatment.  Full Article

Syngenta AG names J. Erik Fyrwald as CEO from June 1
Wednesday, 4 May 2016 01:00am EDT 

Syngenta AG:Names J. Erik Fyrwald as CEO from June 1.  Full Article

BRIEF-Syngenta H1 EBITDA $1.7 bln

* H1 SALES $6.9 BILLION: 2 PERCENT LOWER COMPARED WITH H1 2016